| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.002 | 0.9 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.002 | 0.9 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.0031 | 1 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.0028 | 1 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |